SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012579
Filing Date
2022-08-08
Accepted
2022-08-08 14:05:46
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20220630x10q.htm   iXBRL 10-Q 2500680
2 EX-31.1 clvs-20220630xex31d1.htm EX-31.1 15506
3 EX-31.2 clvs-20220630xex31d2.htm EX-31.2 15701
4 EX-32.1 clvs-20220630xex32d1.htm EX-32.1 6399
5 EX-32.2 clvs-20220630xex32d2.htm EX-32.2 6473
  Complete submission text file 0001558370-22-012579.txt   10045996

Data Files

Seq Description Document Type Size
6 EX-101.SCH clvs-20220630.xsd EX-101.SCH 59356
7 EX-101.CAL clvs-20220630_cal.xml EX-101.CAL 68324
8 EX-101.DEF clvs-20220630_def.xml EX-101.DEF 191194
9 EX-101.LAB clvs-20220630_lab.xml EX-101.LAB 517405
10 EX-101.PRE clvs-20220630_pre.xml EX-101.PRE 358375
72 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20220630x10q_htm.xml XML 2209606
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 221143754
SIC: 2834 Pharmaceutical Preparations